Company / FCF Margin
Atara Biotherapeutics, Inc. FCF Margin History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-42.2%
FY2025
5-year range
-2265.3% / -42.2%
FY2024-FY2025
Trend
+98.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-42.2% in FY2025.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 98.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -73.54 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -42.2% | +98.1% |
| FY2024 | -2265.3% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026